Novartis lies threaten our lives : Act Up-Basel launched to declare the war on pharma - Actup

?article24

  • Novartis lies threaten our lives : Act Up-Basel launched to declare the war on pharma - Actup - Basel
    http://www.actupbasel.org/actupbasel/spip.php?article24

    Tomorrow in New Delhi, the next hearing of the case brought by the Basel-based pharmaceutical firm Novartis against the Indian government is scheduled to take place. Novartis is challenging a critical health safeguard – section 3(d) of Indian Patents Act in the Supreme Court of India – to secure monopoly control over its life-saving cancer medicine, Glivec. In essence, Novartis wants section 3(d), which requires stringent evidence of proof of significantly enhanced therapeutic efficacy if a modification of an existing pharmaceutical entity is to receive new patent protection, to be reinterpreted to allow routine “ever-greening” of minor modifications to existing medicines resulting in additional 20-year patent monopolies. If Novartis wins this case, the ability of India to produce cheap generic medicines of slightly modified molecules will be strongly affected as it will set a precedent for all future patent applications.

    #cancer #brevets #inde #evergreening #pharma